Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

  • APAC
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    CDMO
    Life Science AI
    Supplement Manufacturing
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
OCTOBER 2024LIFE SCIENCES REVIEW 19THERAPEUTICSTOP10 COMPANIES IN APAC 2024Protagonist Therapeutics focuses on discovering and developing peptide-based therapies to treat diseases with significant unmet medical needs. Their innovative approach includes using oral peptides to target biological pathways, with key candidates in clinical trials for conditions like polycythemia vera and psoriasis. Their commitment to patient-centric innovation drives their clinical programs .Protagonist Therapeuticsprotagonist-inc.comY-Biologics is a biopharmaceutical company specializing in the discovery and development of novel antibody therapeutics. The company has developed advanced platforms, including a competitive human antibody library and bispecific antibody formats, with a focus on immuno-oncology. Their lead candidate, YBL-006, is currently undergoing clinical trials for cancer treatment .Y-Biologicsybiologics.comRowan is a digital therapeutics company dedicated to enhancing healthcare through artificial intelligence and medical expertise. It develops personalized solutions targeting cognitive impairment and neurological disorders. By harnessing big data, Rowan aims to improve patient outcomes and advance the future of digital health technologies .Rowanrowan.krStructure Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative oral treatments for chronic metabolic and cardiopulmonary conditions with unmet medical needs. Utilizing a structure-based drug discovery platform, they have established a robust pipeline featuring small molecule compounds that aim to overcome the limitations of traditional therapies.Structure Therapeuticsstructuretx.com
< Page 9 | Page 11 >